Early Phase Oncology Solutions
Dedication in Early Phase Oncology.
To provide optimized solutions.
This shift towards smaller early phase oncology trials is likely to continue. We can develop more targeted and effective treatments to test in smaller trials; ultimately leading to better outcomes for cancer patients. However, there are ample challenges like slow recruitment, logistic inconveniences, and a limited number of available KOLs.
As a specialized contract research organizations for Early Phase Oncology, we help improve the odds of success by providing expertise and services throughout the clinical trial process. Our experts are an extension of your team, offering immediate support aligning with your operations.
Oncology Trials in a Shifting Economical & Geopolitical Landscape
Join our experts and learn about global tendencies in oncology clinical trials and how to adapt to them.
The right combination of experience, facilities, and access to patients to accelerate oncology research.
Experience in Early Phase Oncology
Our distinctive combination of experience across indications and unparalleled access to patients in Eastern Europe make us a bespoke partner for your next Early Phase Oncology trial. Over the last years our clinical trial professionals supported over various oncology programs and many novel therapies throughout their careers. Applying their science and risk-based approach for oncology studies results in the early identification of potential challenges and helps devise the right strategy and solution to prevent setbacks later during regulatory submission
Completed or ongoing Oncology Trials
Start-up / Submission Projects
Oncology Patients Recruited
Colleagues Experience in Oncology
Early Phase Oncology Insights
Clinical Safety Outsourcing: When It Makes Sense for Biotech Companies
Learn when clinical safety outsourcing becomes the right choice for biotechs and how clinical safety management supports growing clinical trials.
Celebrating 25 Years of Biomapas
This year we marked 25 years since Biomapas was founded. What began as a local Lithuanian CRO has evolved into a global organization, delivering integrated regulatory affairs, pharmacovigilance, medical information, and clinical operations to clients across Europe,...
How Medical Information Insights Add Strategic Value to Pharma and Biotech
Why medical information is more than a compliance function — and how consistent, unified insight turns everyday inquiries into strategic value across safety, strategy, and decision-making.
Contact Us
Contact us to learn about how we can enhance your clinical development, accelerate your path to Market Authorisation, and ensure compliance with local and global Post-Marketing requirements.
